As of May 2022 Athersys has a market cap of $0.16 Billion. This makes Athersys the world's 5577th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.14 B | -30.84% |
2021 | $0.21 B | -39.93% |
2020 | $0.35 B | 79.83% |
2019 | $0.19 B | -5.41% |
2018 | $0.20 B | -3.15% |
2017 | $0.21 B | 63.44% |
2016 | $0.13 B | 52.23% |
2015 | $0.08 B | -29.77% |
2014 | $0.12 B | -30.52% |
2013 | $0.17 B | 214.19% |
2012 | $0.05 B | 38.32% |
2011 | $0.04 B | -13.04% |
2010 | $0.04 B | -40.19% |
2009 | $0.07 B | 817.64% |
2008 | $8.51 M | -90.83% |
2007 | $0.09 B |
On May 16th, 2022 the market cap of Athersys was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $468.59 B | 280,071.64% | ๐บ๐ธ USA |
![]() Pfizer PFE | $284.30 B | 169,883.02% | ๐บ๐ธ USA |
![]() Amgen AMGN | $130.27 B | 77,790.49% | ๐บ๐ธ USA |
![]() Sanofi SNY | $131.25 B | 78,378.68% | ๐ซ๐ท France |
![]() Merck MRK | $233.45 B | 139,483.53% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $163.74 B | 97,802.29% | ๐บ๐ธ USA |
![]() Moderna
MRNA | $54.19 B | 32,304.97% | ๐บ๐ธ USA |
![]() Arena Pharmaceuticals
ARNA | $6.16 B | 3,586.19% | ๐บ๐ธ USA |